Skip to content

News and Multimedia Featuring DSIR

Groundbreaking Suicide Study

Science Update

depressed female blonde thumbnail

A groundbreaking study will help researchers learn more about treating people with suicidal thoughts. Nearly 20,000 patients will be able to enroll in the trial. One of the treatments being tested was developed with the help of other patients

Continue Reading…

Increased Health Risks Linked to First-episode Psychosis

Press Release

Recovery After an Initial Schizophrenia Episode

Many patients with psychosis develop health risks associated with premature death early in the course of their mental illness, researchers have found.

Continue Reading…

Personalized Screen to ID Suicidal Teens in 14 ERs

Science Update

A new study will develop and test a personalized, computer-based suicide risk screening tool to help ERs identify troubled teenagers.

Continue Reading…

New grants fund cross-lifespan services research for autism spectrum disorder

Press Release

National Institute of Mental Health

NIH-funded projects aim at improving access, timeliness of interventions.

Continue Reading…

Schizophrenia’s Genetic “Skyline” Rising

Press Release

Schizophrenia genetics Manhattan plots, 2011, 2014

The largest genomic dragnet of any psychiatric disorder to date has unmasked 108 chromosomal sites harboring inherited variations in the genetic code linked to schizophrenia, 83 of which had not been previously reported.

Continue Reading…

How Might New Neurons Buffer Against Stress?

Science Update

new neurons born in adult dentate gyrus

Over the past decade or so, evidence has emerged suggesting that the birth of new neurons in the adult brain’s memory hub, or hippocampus, may play a key role the action of antidepressants, resilience to stress, the benefits of exercise and enriched environments, and preventing memory loss. But understanding how it might work has remained elusive. NIMH researchers in NIH’s new Porter Neuroscience Research Center are following up leads.

Continue Reading…

For Schizophrenia, Newer Injectables Not Necessarily Better

Science Update

concerned female woman patient giving info to doctor

Treatment adherence is a problem among people with schizophrenia, who may not take medications because they don’t perceive its need or benefit, don’t like the side effects, or forget. To combat this issue, long-acting injectable medications are administered every 2-4 weeks. But are the new forms of these drugs better than the old ones?

Continue Reading…

NIMH Director Honored by BBRF

Science Update

NIMH Director Thomas Insel, M.D.

NIMH Director Honored by the Brain and Behavior Research Foundation

Continue Reading…

Channel Makeover Bioengineered to Switch Off Neurons

Press Release

excitatory cellular channel

Scientists have bioengineered an enhancement to a cutting edge technology that provides instant control over brain circuit activity with a flash of light. The research adds the same level of control over switching neurons off that, until now, had been limited to switching them on. What had been working through a weak pump now works through a highly responsive channel -- like going from a squirt to a gushing hose.

Continue Reading…

NIMH’s Dr. Robert Heinssen Receives Special Presidential Commendation from APA

Science Update

NIMH’s Dr. Robert Heinssen Receives Special Presidential Commendation from APA

NIMH’s Dr. Robert Heinssen Receives Special Presidential Commendation from APA

Continue Reading…